MyAverix Finance
SA · Healthcare
IDEXX Laboratories, Inc. (I1DX34)
Diagnostics & Research
IDEXX Laboratories, Inc. (I1DX34) is listed on SA in the Healthcare sector. Industry: Diagnostics & Research. As of 2026-03-29, reported market cap is $239.84B, P/E ratio is 43.20, net margin is 24.6%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for I1DX34
IDEXX Laboratories, Inc. (I1DX34) — FAQ
What is IDEXX Laboratories, Inc.'s market cap?
IDEXX Laboratories, Inc. (I1DX34) has a reported market cap of $239.84B (data as of 2026-03-29).
What is I1DX34's P/E ratio?
The price-to-earnings (P/E) ratio for IDEXX Laboratories, Inc. (I1DX34) is 43.20 (data as of 2026-03-29).
Does IDEXX Laboratories, Inc. pay a dividend?
Dividend yield is not available in the current snapshot for IDEXX Laboratories, Inc. (I1DX34). Check the MyAverix Finance app for the latest dividend data.
What sector is IDEXX Laboratories, Inc. in?
IDEXX Laboratories, Inc. (I1DX34) is classified in the Healthcare sector (Diagnostics & Research industry).
What exchange is I1DX34 listed on?
I1DX34 is listed on SA.
What is IDEXX Laboratories, Inc.'s net margin?
IDEXX Laboratories, Inc. (I1DX34) reports a net margin of 24.6% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.